Recumbency after Oclacitinib (Apoquel) in dogs

The FDA has received 39 reports of recumbency in dogs after Oclacitinib. That is 0.1% of all reports for this medicine, compared with 0.4% across reports for all dog medicines, so it is reported less often than average with this medicine.

39Reports
79%Marked serious
26%Recovered
41%Died or euthanised
25 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
8 24%
1–2 days
4 12%
3–7 days
3 8.8%
1–4 weeks
5 15%
Over a month
14 41%

How the animals did

Recovered
10 26%
Still unwell when reported
11 28%
Died
10 26%
Euthanised
6 15%
Not known
2 5.1%

Problems reported at the same time

Age of the animals

Under 1 year
0
1–3 years
5
4–7 years
14
8–11 years
15
12+ years
5

About this medicine

Oclacitinib controls itching from allergies (tablet, a JAK inhibitor).

Products with this ingredient include Apoquel. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Oclacitinib cause recumbency in dogs?
39 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 25 days of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Recumbency with similar medicines

All reported side effects of Oclacitinib in dogs · Medicines most reported with recumbency